KELLY GALVIN: Open Payments
NPI 1518438001 · KING OF PRUSSIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 54 payments from 9 companies in 2025. Trend: 2023 $1,602 · 2024 $3,274 · 2025 $1,616
Food & beverage: $1,547Education: $69
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $454 |
| Abbott Laboratories | 18 | $266 |
| Lilly USA, LLC | 9 | $243 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $167 |
| Novo Nordisk Inc | 4 | $165 |
| Insulet Corporation | 2 | $133 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Ascensia Diabetes Care Us Inc. | 1 | $49 |
| Sequel Med Tech, LLC | 1 | $15 |
Products named: MINIMED 780G, FREESTYLE LIBRE 3, MOUNJARO, Omnipod, LUMRYZ, ZEPBOUND, JARDIANCE, Ozempic.
Industry payments across PA — which companies pay providers there.
